Clinical predictors of response to cognitive-behavioral therapy in pediatric anxiety disorders: The Genes for Treatment (GxT) Study

Jennifer L Hudson, Robert Keers, Susanna Roberts, Jonathan R I Coleman, Gerome Breen, Kristian Arendt, Susan Bögels, Peter Cooper, Cathy Creswell, Catharina Hartman, Einar R Heiervang, Katrin Hötzel, Tina In-Albon, Kristen Lavallee, Heidi J Lyneham, Carla E Marin, Anna McKinnon, Richard Meiser-Stedman, Talia Morris, Maaike NautaRonald M Rapee, Silvia Schneider, Sophie C Schneider, Wendy K Silverman, Mikael Thastum, Kerstin Thirlwall, Polly Waite, Gro Janne Wergeland, Kathryn J Lester, Thalia C Eley

Research output: Contribution to journalArticlepeer-review

111 Citations (Scopus)
19 Downloads (Pure)


The Genes for Treatment study is an international, multisite collaboration exploring the role of genetic, demographic, and clinical predictors in response to cognitive-behavioral therapy (CBT) in pediatric anxiety disorders. The current article, the first from the study, examined demographic and clinical predictors of response to CBT. We hypothesized that the child's gender, type of anxiety disorder, initial severity and comorbidity, and parents' psychopathology would significantly predict outcome.
Original languageEnglish
Pages (from-to)454-463
Number of pages10
JournalJournal of the American Academy of Child & Adolescent Psychiatry
Issue number6
Early online date1 Apr 2015
Publication statusPublished - Jun 2015


  • anxiety disorders
  • treatment
  • predictors
  • cognitive-behavioral therapy

Cite this